UNSPSC 51422331: Betamethasone valerate

This classification denotes a therapeutic glucocorticoid with the molecular formula C27H37FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9IFA5XM7R2, chemically known as 16-beta-methyl-1,4-pregnadiene-9-alpha-fluoro-11-beta,17-alpha,21-triol-3,20-dione but more generally known as betamethasone valerate, which bears US NIH Compound Identifier 9782.

The base compound, Betamethasone, comes in many other forms, including base, acetate, acetate phosphate, acibutate, alcohol, benzoate, butyrate propionate, dihydrogen phosphate, dipropionate, disodium phosphate, phosphate, sodium, sodium phosphate, 17-acetate, 17 alpha-monopropionate, 17-benzoate, 17-dipropionate, 17-propionate, 17-propionate 21-methoxide, 17-valerate, 21-acetate, 21-disodium phosphate, 21-pentanoate, 21-phosphate, and 21-phosphate disodium.

UNSPSC 51422331 Betamethasone valerate is a Commodity code representing a specific topical corticosteroid medication. State and local governments procure this pharmaceutical under the code primarily through health departments, community health programs, and county public health initiatives that stock it for clinical use or emergency preparedness distribution. The actual buying activity shows minimal recent state and local procurement specifically tagged to this code; the single recent opportunity identified—Seminole County's IFB for naloxone and drug deactivation systems—falls outside the betamethasone valerate scope and reflects a mismatch between the coded classification and the solicitation's true subject matter.

The geographic and temporal record supports no substantive recent activity under this code. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023 (a temporal inconsistency in the source), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford—a procurement entirely unrelated to betamethasone valerate. This code shows little relevant recent activity and warrants a watch posture rather than active pursuit until state and local issuers post opportunities that genuinely align with topical corticosteroid procurement.